Rockefeller Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed 2593
2022
Q4
$0 Hold
4
﹤0.01% 3950
2022
Q3
$0 Sell
4
-34
-89% ﹤0.01% 4015
2022
Q2
$0 Sell
38
-74
-66% ﹤0.01% 4183
2022
Q1
$4K Buy
112
+104
+1,300% +$3.71K ﹤0.01% 3403
2021
Q4
$0 Buy
+8
New ﹤0.01% 3827
2021
Q3
Sell
-8
Closed 3732
2021
Q2
$0 Buy
+8
New ﹤0.01% 3485